Written by Researchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery, identifying genetic connections between inflammatory bowel disease (IBD) and Parkinson’s disease (PD). Published in Genome Medicine on May 14, their study highlights the potential for joint therapeutic strategies to target these two challenging disorders. The paper is titled, “The landscape of rare genetic variation associated with inflammatory bowel disease and Parkinson’s disease comorbidity.”
Medical Xpress – latest medical and health news stories